TIDMAMC

RNS Number : 6375L

Amur Minerals Corporation

07 September 2023

7 September 2023

Amur Minerals Corporation

("Amur" or the "Company")

Suspension of trading on AIM

Amur Minerals Corporation (AIM: AMC) confirms that trading in the Company's shares on AIM will be suspended with effect from 7.30 a.m. BST today.

As stated in the Company's notification of 6 March 2023, following the disposal of the Company's AO Kun-Manie subsidiary, Amur became classified as an AIM Rule 15 cash shell from that date, and as such was required to make an acquisition or acquisitions which would constitute a reverse takeover under Rule 14 of the AIM Rules for Companies, or be re-admitted on AIM as an investing company under the AIM Rules on or before the date falling six months from 6 March 2023.

As neither a reverse takeover nor readmission to trading on AIM as an investing company have been completed, trading in the Company's shares on AIM will now be suspended today.

Trading will remain suspended until the completion of a reverse takeover, which requires the publication of an admission document and the approval of such a transaction at a General Meeting of the Company, or the Company is readmitted to trading on AIM as an investing company.

If no such transaction is completed within six months, the Company's shares will be cancelled from trading on AIM pursuant to AIM Rule 41. There can be no assurance that the Company will be able to complete a reverse takeover during the six-month suspension period.

The board of Amur continues to review a number of reverse takeover opportunities. Further announcements will be made as appropriate.

Enquiries:

 
       Company            Nomad and Broker        Public Relations 
  Amur Minerals Corp.    S.P. Angel Corporate         BlytheRay 
                             Finance LLP 
   Robin Young CEO        Richard Morrison           Megan Ray 
                              Adam Cowl              Tim Blythe 
                           +44 (0) 20 3470 
 +44 (0) 7981 126 818            0470           +44 (0) 20 7138 3203

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCDGGDCSXGDGXL

(END) Dow Jones Newswires

September 07, 2023 02:00 ET (06:00 GMT)

Crism Therapeutics (AQSE:AMC.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Crism Therapeutics Charts.
Crism Therapeutics (AQSE:AMC.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Crism Therapeutics Charts.